Search Results - "KLIFFEN, Mike"

Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome by van der Slot, Margaretha A., Hollemans, Eva, den Bakker, Michael A., Hoedemaeker, Robert, Kliffen, Mike, Budel, Leo M., Goemaere, Natascha N. T., van Leenders, Geert J. L. H.

“…The Grade group is an important parameter for clinical decision-making in prostate cancer. Recently, percent Gleason pattern 4 and presence of invasive…”
Get full text

Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional study by Achterberg, Friso B, Mulder, Babs G Sibinga, Janssen, Quisette P, Koerkamp, Bas Groot, Hol, Lieke, Quispel, Rutger, Bonsing, Bert A, Vahrmeijer, Alexander L, van Eijck, Casper H J, Roos, Daphne, Perk, Lars E, van der Harst, Erwin, Coene, Peter-Paul L O, Doukas, Michail, Smedts, Frank M M, Kliffen, Mike, van Velthuysen, Marie-Louise F, Terpstra, Valeska, Sarasqueta, Arantza Farina, Morreau, Hans, Mieog, J Sven D

“…The diagnostic process of patients with suspect pancreatic lesions is often lengthy and prone to repeated diagnostic procedures due to inconclusive results…”
Get full text

Anisometric Cell and Dysplastic Lipomas in a Retinoblastoma Patient by den Bakker, Michael A., den Toom, Dorine T., Damen, Tim H. C., Sleddens, Hein F. B. M., Meijssen, Isabella C., Deloose, Stijn, Kliffen, Mike, Dinjens, Winand N. M.

“…Anisometric cell lipoma (ACL) and dysplastic lipoma (DL) are underrecognized subtypes of benign lipomatous tumors, with wide variation in cell size,…”
Get full text

Giant-cell Arteritis of the Ovarian Arteries: A Rare Manifestation of a Common Disease by Theunissen, Prisca, Kliffen, Mike, Dees, Ad

“…We describe a 58-year-old woman presenting with headache and an elevated erythrocyte sedimentation rate (ESR), who was diagnosed with and successfully treated…”
Get full text

Cumulative sum learning curves guiding multicenter multidisciplinary quality improvement of EUS-guided tissue acquisition of solid pancreatic lesions by Schutz, Hannah M., Quispel, Rutger, Veldt, Bart J., Smedts, Frank M.M., Anten, Marie-Paule G.F., Hoogduin, Klaas J., Honkoop, Pieter, van Nederveen, Francien H., Hol, Lieke, Kliffen, Mike, Fitzpatrick, Claire E., Erler, Nicole S., Bruno, Marco J., van Driel, Lydi M.J.W.

“…Abstract Background and study aims In this study, we evaluated the performance of community hospitals involved in the Dutch quality in endosonography team…”
Get full text

Giant solitary fibrous tumour of the liver by Terkivatan, Türkan, Kliffen, Mike, de Wilt, Johannes H W, van Geel, Albertus N, Eggermont, Alexander M M, Verhoef, Cornelis

“…Solitary fibrous tumour (SFT) is an uncommon mesenchymal neoplasm that most frequently affects the pleura, although it has been reported with increasing…”
Get full text

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience by Lamers, Cor H J, Sleijfer, Stefan, Vulto, Arnold G, Kruit, Wim H J, Kliffen, Mike, Debets, Reno, Gratama, Jan W, Stoter, Gerrit, Oosterwijk, Egbert

Get full text

MP50-02 OUTCOMES AFTER INTRODUCING INTRAOPERATIVE FROZEN SECTIONS IN ROBOT-ASSISTED RADICAL PROSTATECTOMY by van der Slot, Michelle, Bakker, Michael den, Kweldam, Charlotte, Remmers, Sebastiaan, Tan, Tamara, Klaver, Sjoerd, Kliffen, Mike, Busstra, Martijn, Rietbergen, John, Gan, Melanie, Hamoen, Karen, Budel, Leo, Goemaere, Natascha, Bangma, Chris, Helleman, Jozien, Roobol, Monique, van leenders, Geert

Get full text

Artificial Intelligence-based Segmentation of Residual Pancreatic Cancer in Resection Specimens Following Neoadjuvant Treatment (ISGPP-2): International Improvement and Validation Study by Janssen, Boris V, Oteman, Bart, Ali, Mahsoem, Valkema, Pieter A, Adsay, Volkan, Basturk, Olca, Chatterjee, Deyali, Chou, Angela, Crobach, Stijn, Doukas, Michael, Drillenburg, Paul, Esposito, Irene, Gill, Anthony J, Hong, Seung-Mo, Jansen, Casper, Kliffen, Mike, Mittal, Anubhav, Samra, Jas, van Velthuysen, Marie-Louise F, Yavas, Aslihan, Kazemier, Geert, Verheij, Joanne, Steyerberg, Ewout, Besselink, Marc G, Wang, Huamin, Verbeke, Caroline, Fariña, Arantza, de Boer, Onno J

“…Neoadjuvant therapy (NAT) has become routine in patients with borderline resectable pancreatic cancer. Pathologists examine pancreatic cancer resection…”
Get full text

NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome by Slot, Margaretha A., Bakker, Michael A., Tan, Tamara S. C., Remmers, Sebastiaan, Busstra, Martijn B., Gan, Melanie, Klaver, Sjoerd, Rietbergen, John B. W., Kweldam, Charlotte F., Kliffen, Mike, Hamoen, Karen E., Budel, Leo M., Goemaere, Natascha N. T., Helleman, Jozien, Bangma, Chris H., Roobol, Monique J., Leenders, Geert J. L. H.

“…Objectives To investigate the impact of intra‐operative neurovascular structure‐adjacent frozen‐section examination (NeuroSAFE) on the rate of nerve‐sparing…”
Get full text

Bite-on-bite biopsies for the detection of residual esophageal cancer after neoadjuvant chemoradiotherapy by van der Bogt, Ruben D, van der Wilk, Berend J, Oudijk, Lindsey, Schoon, Erik J, van Lijnschoten, Gesina, Corporaal, Sietske, Nieken, Judith, Siersema, Peter D, Bisseling, Tanya M, van der Post, Rachel S, Quispel, Rutger, van Tilburg, Arjan, Oostenbrug, Liekele E, Riedl, Robert G, Hol, Lieke, Kliffen, Mike, Nikkessen, Suzan, Eyck, Ben M, van Lanschot, J Jan B, Doukas, Michael, Spaander, Manon C W

“…Active surveillance after neoadjuvant treatment is increasingly implemented. The success of this strategy relies on the accurate detection of residual cancer…”
Get more information

Artificial intelligence-based quantification of residual cancer burden to evaluate the impact of neoadjuvant therapy in resected pancreatic cancer in the PREOPANC randomised trial by Janssen, Boris, van Dieren, Susan, Bonsing, Bert, Busch, Olivier, Crobach, Stijn, Doukas, Michael, Drillenburg, Paul, Gerhards, Michael, Groot-Koerkamp, Bas, Kliffen, Mike, Mieog, Sven, van der Harst, Erwin, Verheij, Joanne, Wilmink, Johanna, van Tienhoven, Geertjan, van Eijck, Casper, Versteijne, Eva, Kazemier, Geert, de Boer, Onno, Farina, Arantza, Besselink, Marc

Get full text

Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve‐sparing surgery in prostate cancer patients (NeuroSAFE) by Slot, Margaretha A, Bakker, Michael A, Klaver, Sjoerd, Kliffen, Mike, Busstra, Martijn B, Rietbergen, John B W, Gan, Melanie, Hamoen, Karen E, Budel, Leo M, Goemaere, Natascha N T, Bangma, Chris H, Helleman, Jozien, Roobol, Monique J, Leenders, Geert J L H

“…Aims Radical prostatectomy for prostate cancer is frequently complicated by urinary incontinence and erectile dysfunction. Nerve‐sparing surgery reduces the…”
Get full text

Partial versus complete prostatectomy specimen sampling: prospective non-inferiority study for pT3a tumours and surgical margin involvement by Collette, Eelco R P, den Bakker, Michael A, Klaver, Sjoerd O, Vis, André N, Kliffen, Mike

“…AimsThe importance of additional information gained by complete versus partial sampling or prostatectomy specimens is uncertain. There is sparse data on the…”
Get full text

GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells by Rakké, Yannick S., Campos Carrascosa, Lucia, van Beek, Adriaan A., de Ruiter, Valeska, van Gemerden, Rachelle S., Doukas, Michail, Doornebosch, Pascal G., Vermaas, Maarten, ter Borg, Susan, van der Harst, Erwin, Coene, Peter Paul L.O., Kliffen, Mike, Grünhagen, Dirk J., Verhoef, Cornelis, IJzermans, Jan N.M., Kwekkeboom, Jaap, Sprengers, Dave

“…In contrast to mismatch repair deficient colorectal carcinoma (CRC), MMR proficient (pMMR) CRC does not respond to immune checkpoint blockade. We studied…”
Get full text

GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T CellsSummary by Yannick S. Rakké, Lucia Campos Carrascosa, Adriaan A. van Beek, Valeska de Ruiter, Rachelle S. van Gemerden, Michail Doukas, Pascal G. Doornebosch, Maarten Vermaas, Susan ter Borg, Erwin van der Harst, Peter Paul L.O. Coene, Mike Kliffen, Dirk J. Grünhagen, Cornelis Verhoef, Jan N.M. IJzermans, Jaap Kwekkeboom, Dave Sprengers

“…Background & Aims: In contrast to mismatch repair deficient colorectal carcinoma (CRC), MMR proficient (pMMR) CRC does not respond to immune checkpoint…”
Get full text

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer by De Marchi, Tommaso, Liu, Ning Qing, Stingl, Cristoph, Timmermans, Mieke A., Smid, Marcel, Look, Maxime P., Tjoa, Mila, Braakman, Rene B.H., Opdam, Mark, Linn, Sabine C., Sweep, Fred C.G.J., Span, Paul N., Kliffen, Mike, Luider, Theo M., Foekens, John A., Martens, John W.M., Umar, Arzu

“…Estrogen receptor (ER) positive tumors represent the majority of breast malignancies, and are effectively treated with hormonal therapies, such as tamoxifen…”
Get full text

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer by De Marchi, Tommaso, Timmermans, Anne M, Smid, Marcel, Look, Maxime P, Stingl, Christoph, Opdam, Mark, Linn, Sabine C, Sweep, Fred C G J, Span, Paul N, Kliffen, Mike, van Deurzen, Carolien H M, Luider, Theo M, Foekens, John A, Martens, John W, Umar, Arzu

“…Tamoxifen therapy resistance constitutes a major cause of death in patients with recurrent estrogen receptor (ER) positive breast cancer. Through high…”
Get full text

Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours by de Jong, Jeroen, Stoop, Hans, Dohle, Gert R, Bangma, Chris H, Kliffen, Mike, van Esser, Joost WJ, van den Bent, Martin, Kros, Johan M, Oosterhuis, JW, Looijenga, Leendert HJ

“…Human testicular germ cell tumours of adolescents and adults (TGCTs), the seminomatous and non‐seminomatous germ cell tumours, show morphological and…”
Get full text

HER2 gene amplification in patients with breast cancer with equivocal IHC results by Meijer, Sybren L, Wesseling, Jelle, Smit, Vincent T, Nederlof, Petra M, Hooijer, Gerrit K J, Ruijter, Henrique, Arends, Jan Willem, Kliffen, Mike, van Gorp, Joost M, Sterk, Lotus, van de Vijver, Marc J

“…Equivocal human epidermal growth factor receptor 2 protein (HER2) (2+) immunohistochemistry (IHC) is subject to significant interobserver variation and poses a…”
Get more information